[Factors which influence infavourably l-dopa treatment].
D000284:Administration, Oral; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D014282:Trihexyphenidyl / Q000627:therapeutic use
D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl
Faktorer som influerer uheldig på l-dopabehandlingen.